mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.3 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.057 |
0.3 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |